WILFREDO VILLARRUBIA: Open Payments
NPI 1568992030 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 41 payments from 16 companies in 2025. Trend: 2023 $1,361 · 2024 $1,203 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $214 |
| Amgen Inc. | 9 | $141 |
| GlaxoSmithKline, LLC. | 3 | $95 |
| UCB, Inc. | 4 | $88 |
| Fresenius Kabi USA, LLC | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Aurinia Pharma U.S., Inc. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $24 |
| Organon LLC | 1 | $22 |
Products named: SKYRIZI, BENLYSTA, Bimzelx, RINVOQ, SAPHNELO, EVENITY, LUPKYNIS, TAVNEOS.
Industry payments across SC — which companies pay providers there.
